Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece
- PDF / 555,539 Bytes
- 10 Pages / 595.276 x 790.866 pts Page_size
- 60 Downloads / 184 Views
(2020) 20:253
RESEARCH ARTICLE
Open Access
Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece Despo Ierodiakonou1,2†, Dimitra Sifaki-Pistolla1,3†, Maria Kampouraki4, Ioannis Poulorinakis5, Polyvios Papadokostakis6, Ioannis Gialamas7, Polyxeni Athanasiou2, Vasiliki Bempi2, Irene Lampraki2, Ioanna Tsiligianni1* and On behalf of the Greek UNLOCK group
Abstract Background: Comorbidities and adherence to inhaled therapy appears to have a major impact on treatment goals, health status and disease control in chronic obstructive pulmonary disease (COPD). Aim of the study was to assess levels of adherence to inhalers, comorbidities and associations with COPD outcomes in patients residing in rural and semi-urban areas of Greece. Methods: Two hundred fifty-seven COPD patients were enrolled from primary health care in 2015–2016. Physicians used structured interviews and questionnaires to assess quality of life and disease status. Patients were classified into groups according to GOLD 2019 guidelines (based on CAT and mMRC). Adherence to inhalers was measured with the Test of Adherence to Inhalers (TAI). Multivariate linear and logistics regression models were used to assess associations between comorbidities and adherence to inhalers with COPD outcomes, including CAT and mMRC scores, exacerbations and GOLD A-D status. Results: 74.1% of COPD patients reported poor adherence, while most of them were characterized as deliberate non-compliers (69.5%). 77.1% had ≥2 comorbidities, with overweight/obese (82.2%), hypertension (72.9%) and diabetes mellitus (58%) being the most prevalent. In multivariate analysis, COPD outcomes having significant associations with poor adherence included worse health status [OR (95% CI) 4.86 (1.61–14.69) and 2.93 (1.51–5.71) based on CAT and mMRC, respectively], having ≥2 exacerbations in the past year [4.68 (1.51–4.44)], and disease status e.g., be in groups C or D [3.13 (1.49–8.53) and 3.35 (1.24–9.09) based on CAT and mMRC, respectively). Subjects with gastroesophageal reflux showed better inhaler adherence [OR (95% CI) 0.17 (0.6–0.45)], but none of the comorbid conditions was associated with COPD outcomes after adjustments. Conclusions: Poor adherence to inhalers and comorbidities are both prevalent in COPD patients of primary care residing in rural/semi-urban areas of Greece, with adherence influencing COPD outcomes. Raising awareness of patients and physicians on the importance of comorbidities control and inhaler adherence may lead to interventions and improve outcomes. Keywords: COPD, Adherence, Comorbidities, Exacerbations, Health status, GOLD2019 * Correspondence: [email protected] † Despo Ierodiakonou and Dimitra Sifaki-Pistolla contributed equally to this work. 1 Health Planning Unit. Department of Social Medicine, Faculty of Medicine, University of Crete, Voutes Campus, Heraklion, GR-71003 Crete, Greece Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licens
Data Loading...
